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1. Introduction
  Lung ischemia-reperfusion injury (LIRI) is clinical common 
in lung transplantation and extracorporeal circulation 
operation[1-3]. LIRI can lead to lung dysfunction, and is the 
leading cause of death after lung transplantation[4]. Studyhas 
showed that[5], enflurane and sevoflurane drugs play an 
important protective role in viscera reperfusion. Other 
studies have suggested[6] that sevoflurane pretreatment 
can significantly reduce the lung edema and inflammation 
induced by tissue endotoxin, and sevoflurane can protect 
on LIRI. This study aimed to observe the influence of 
sevoflurane on LIRI rat lung tissue permeability and the 
mechanism. We established the rat lung LIRI model, used 
sevoflurane pretreatment, observe its tissue permeability 
and the pathological changes, to provide the theory basis for 
clinical prevention and treatment of LIRI medication.
2. Materials and methods
2.1.  Experimental animals
  A total of 45 male, clean level, Wistar rats were selected, 
aged 8 to 10 weeks, weighting (251.3依42.5) g. They were 
provided by the laboratory animal center, class 栻, and 
had free food and water. The experimental process strictly 
followed “regulations on the administration of experimental 
animals”.
Objective: To investigate the effect of sevoflurane on tissue permeability of lung ischemia-
reperfusion injury (LIRI) in rats. Methods: A total of 45 wistar rats were randomly divided into 
3 groups 栺, 栻, 栿. Modified Eppinger method was adopted to establish the rat lung ischemia-
reperfusion injury model. Group栺 served as the control group, group 栻 as ischemia reperfusion 
group, group 栿 as sevoflurane ischemia-reperfusion group. Blood gas index, lung permeability 
index (LPI) change, lung tissue pathology change and lung water content were observed and 
compared between groups of rats at different time points. Results: During ischemia reperfusion, 
all rats kept balance of the MAP during different time points, SPO2 of group 栻 and 栿 decreased 
significantly than 栺 group (P<0.05); after reperfusion lung permeability index in Group 栻 and 
栿 was higher than the control group significantly (P<0.05), 120 min after reperfusion LPI change 
and injury of group 栿 was significantly lower than 栻 group (P<0.05); interstitial and alveolar 
cavity effusion in of group 栿 were lower than that of group 栻. Conclusions: Sevoflurane 
pretreatment can reduce the lung tissue permeability, and LIRI plays a protective role in LIRI.
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2.2. Instrument and reagent
  SLIRIecust730 pressure monitor (Siemens Germany); Detax 
gas monitor (Finland); NOVAbiomedical blood gas analyzer 
(United States); Optical microscope (BH-2) (Japan). 20% 
urethane (our center reagent); Sevoflurane (Baxter company, 
USA).
2.3. Model establishing
  Eppinger method was used to establish LIRI model in 
rats in vivo[7]. All rats had anesthesia with intraperitoneal 
injection of 20% urethane in supine position. The right 
lower limb groin skin had incision under local anesthesia, 
and right femoral vein was exposed. Sodium chloride was 
injected by infusion pump. After neck midline incision, 
trachea and left carotid artery was separated. Tracheotomy 
was performed for intubation, and animal breathing machine 
was used for mechanical ventilation. The parameters were 
adjusted according to the data. PaCO2 was maintained 
at 35 to 45 mmHg. Left carotid artery blood pressure was 
monitored continuously and blood samples were collected 
at each time point. Vecuronium bromide amine was infused 
continuously to maintain anesthesia, and sevoflurane 
inhalation concentration was adjusted within 1 MAC (2.2%) 
in intraoperative sevoflurane preconditioning group. Thirty 
minutes after mechanical ventilation, the bottom left 
pulmonary ligament was cut off from the fifth rib in left side. 
Pulmonary hilar was exposed, and 50 U heparin was injected 
intravenously. Left pulmonary hilar was closed, and lung 
surface was rinsed with saline. Thoracic cavity was closed 
by suture, after 45 min blood flow was open.
2.4. Animal groups
  A total of 45 Wistar rats were randomly divided into group 
栺, 栻, 栿, with 15 in each. group 栺 served as the control 
group, without block after left pulmonary hilar opening; 
group 栻 as ischemia-reperfusion group, with perfusion 
45 min after left pulmonary hilar blocking; group 栿 as 
sevoflurane ischemia-reperfusion group, with sevoflurane 
inhalation for 30 min and with perfusion 45 min after left 
pulmonary hilar blocking. There were three time points 
in each group, ischemia blocking for 45 min, 1 h and 2 h 
reperfusion. Five rats were sacrificed at each time point.
2.5. Indexes observation
  0.5 mL of blood was collected for blood gas analysis at 
three time points, respectively. Lung wet dry weight ratio 
was detected[8]. Lung tissue was weighted as wet weight 
(W), then they were placed in the oven drying to record dry 
weight (D), to calculate the wet dry /weight ratio (W/D). Lung 
permeability index (LPI) value was obtained by using the 
Bradford method[9]. After perfusion, rats were sacrificed. 
1 mm left lung tissue was selected, fixed, HE stained to 
observe changes in lung tissue;
2.6. Statistical analysis
  SPSS12.0 statistics software was used to analyze data, 
measurement data were expressed as mean依SD, P<0.05 was 
considered as significant difference.
3. Results
3.1. PaCO2 change
  There was no statistical difference in PaCO2 basic value 
between three groups (P>0.05); PaCO2 decreased significantly 
in 栻, 栿 group  60, 120 min after reperfusion (P<0.05), and 
compared with group 栺 the differences was statistically 
significant (P<0.05); decrease in Group 栻 at each time point 
was more significant than that of group 栿, but there was no 
statistically significant difference (P>0.05) (Table 1).
3.2. Lung W/D detection
  There was no statistical difference of rats W/D between 
three groups (P>0.05). 60, 120 min after reperfusion lung W/D 
in group栺had no significant change compared with that at 
ischemia time (P>0.05); 60, 120 min after reperfusion W/D of 
Group 栻 and 栿 was significantly increased compared with 
Table 1
PaCO2 change of three groups at each time point (mmHg).
Group Basic value 45 min after ischemia 1 h after reperfusion 2 h after reperfusion 
Group 栺 101.06依22.34 103.11依22.05 95.23依13.14 98.61依10.23
Group 栻 101.34依26.65   99.93依21.34 48.59依7.61
* 45.86依7.09*
Group 栿 103.21依24.31 104.89依25.21 61.07依5.78
* 57.27依3.38*
*Compared with Group 栺P<0.05.
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that of group 栺 (P<0.05). 60, 120 min after reperfusion W/D 
of Group 栻 was significantly increased compared with that 
of group 栿 (P<0.05) (Table 2).
3.3. LPI 
  120 min after reperfusionLPI of group 栻[(2.73依0.09)%] and 
栿[(1.56依0.18)%] were significantly higher than group 栺[(0.73
依0.13)%] (P<0.05), and the difference was significant different 
between group 栿 and group 栻 (P<0.05).
3.4. Pathological observation
  Group栺showed normal lung tissue structure, a small 
amount of accidental effusion in alveolar space, capillary 
without congestion; group 栻showed lung capillary 
expansion congestion, edema of broadening alveolar 
interval, infiltrated interstitial inflammatory cell, exudated 
red blood cells and inflammatory cells from alveolar lumen. 
Lung tissue structural damage was serious reperfusion 
after 120 min; group 栿 showed that lung tissue injury was 
reduced significantly than group 栻, interstitial and alveolar 
cavity effusion reduced as shown in Figure 1.  
Group 栺                               Group 栻                                 Group 栿
  
Figure 1. Pathological observation (HE×400).
4. Discussion
  LIRI tends to occur in cardiopulmonary resuscitation, 
extracorporeal circulation, lung transplantation, and other 
circumstances. The pathogenesis is not yet clear. Some 
scholars reported  that it is related with many factors, and 
acute LIRI is important factors affecting postoperative 
recovery[10-13]. After rebuilding blood supply, lung tissue 
damage is aggravating[14]. Therefore, the effective prevention 
and control measure is hot spot of clinical research. 
Studies have shown that[15-17], pretreatment with drugs can 
significantly reduce the degree of lung injury. This study 
Eppinger method is adopted to establish the LIRI rats model 
in vivo. Pathological changes of lung tissue were obvious, 
and lung capillary hyperemia and expansion were obvious 
after reperfusion. Alveolar cavities erythrocyte effused 
in great quantities, followed with interstitial edema and 
inflammatory cells infiltration, showing LIRI model was 
successfully established.
  Sevoflurane inhalation anesthesia is common. Studies have 
shown that[18-20], it can improve the lung injury caused by 
endotoxin, alleviate endotoxin induced lung edema and 
inflammatory cell infiltration, without influence on regular 
inhalation of lung tissue. In this study, PaCO2 of group 栻
decreased significantly after infusion. It may be related 
to increasing capillary permeability after lung ischemia 
reperfusion, which lead to pulmonary interstitial edema, 
blood flow to the ventilation/dysfunction ratio[21-23]; In Group 
栿after sevoflurane pretreatment, PaCO2 was increased 
slightly, showing that LIRI has certain protective effect. LPI 
is the main indicators for lung tissue protein permeability. 
In this study, LPI of group 栻 after reperfusion was increased 
most significantly. LPI in group 栿 decreased significantly 
pretreatment than 栻 group after sevoflurane inhalation. It 
also shows that sevoflurane pretreatment can decrease the 
LPI rising degree. The lung D/W ratio in group 栿 was lower 
than that in group 栻, the result changes were positively 
related to the level of the LPI changes, showing sevoflurane 
pretreatment can reduce pulmonary vascular permeability 
after reperfusion. The lung tissue can play a protective role. 
HE staining showed that, tissue damage degree in the group 
栿was significantly lighter than group 栻, which confirmed 
protection effect of sevoflurane pretreatment on LIRI.
  According to the results of this study, pretreatment 
with sevoflurane can improve tissue permeability of lung 




Group Basic value 45 min after ischemia 1 h after reperfusion 2 h after reperfusion
Group 栺 4.41依0.36 4.20依0.20 4.31依0.24 4.31依0.24
Group 栻 4.34依0.26 5.22依0.11 5.67依0.42
*
5.67依0.42*
Group 栿 4.20依0.21 4.88依0.08 5.29依0.12
*△
5.29依0.12*△
*Compared with Group 栺P<0.05; 
△
Compared with Group 栻P<0.05.
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